XML 54 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 30, 2022
Income Tax Disclosure [Abstract]  
Schedule of Income (Loss) before Income Tax, Domestic and Foreign

Income (loss) from continuing operations before provision for income taxes was as follows (in thousands):

 

 

 

Years Ended

 

 

 

2022

 

 

2021

 

 

2020

 

Domestic

 

$

(25,366

)

 

$

(15,565

)

 

$

(16,245

)

Foreign

 

 

70,918

 

 

 

46,869

 

 

 

24,512

 

Income before income taxes

 

$

45,552

 

 

$

31,304

 

 

$

8,267

 

Schedule of Components of Income Tax Expense (Benefit)

The provision (benefit) for income taxes consisted of the following (in thousands):

 

 

 

Years Ended

 

 

 

2022

 

 

2021

 

 

2020

 

Current tax provision:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. federal

 

$

 

 

$

 

 

$

2

 

State

 

 

 

 

 

 

 

 

15

 

Foreign

 

 

8,141

 

 

 

5,308

 

 

 

3,186

 

Total current provision

 

 

8,141

 

 

 

5,308

 

 

 

3,203

 

Deferred tax provision (benefit):

 

 

 

 

 

 

 

 

 

 

 

 

U.S. federal

 

 

(867

)

 

 

739

 

 

 

(573

)

State

 

 

38

 

 

 

106

 

 

 

78

 

Foreign

 

 

(515

)

 

 

650

 

 

 

(354

)

Total deferred provision (benefit)

 

 

(1,344

)

 

 

1,495

 

 

 

(849

)

Provision for income taxes

 

$

6,797

 

 

$

6,803

 

 

$

2,354

 

Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the statutory U.S. federal tax rate to the Company’s effective tax rate was as follows (dollars in thousands):

 

 

 

Years Ended

 

 

 

2022

 

 

2021

 

 

2020

 

 

 

Amount

 

 

Amount

 

 

Amount

 

Income before income taxes

 

$

45,552

 

 

$

31,304

 

 

$

8,267

 

Income tax expense:

 

 

 

 

 

 

 

 

 

 

 

 

Taxes at federal statutory tax rate

 

 

9,566

 

 

 

6,574

 

 

 

1,736

 

State taxes, net of federal income tax benefit

 

 

3,673

 

 

 

(448

)

 

 

(1,129

)

Equity compensation

 

 

1,336

 

 

 

(4,613

)

 

 

(5,203

)

Foreign rate differential

 

 

(7,022

)

 

 

(3,890

)

 

 

(2,304

)

GILTI inclusion

 

 

14,583

 

 

 

171

 

 

 

4,461

 

Valuation allowance

 

 

(15,785

)

 

 

9,302

 

 

 

4,899

 

Other

 

 

446

 

 

 

(293

)

 

 

(106

)

Total income tax expense

 

$

6,797

 

 

$

6,803

 

 

$

2,354

 

Effective tax rate

 

 

14.9

%

 

 

21.7

%

 

 

28.5

%

Schedule of Deferred Tax Assets and Liabilities Significant components of the Company’s deferred tax assets (liabilities) were as follows (in thousands):

 

 

2022

 

 

2021

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Accrued expenses

 

$

2,021

 

 

$

2,450

 

Stock-based compensation

 

 

2,851

 

 

 

2,146

 

Operating lease liability

 

 

6,071

 

 

 

6,894

 

Net operating loss and other credit carryforwards

 

 

36,567

 

 

 

51,323

 

Other deferred tax assets

 

 

1,621

 

 

 

2,682

 

Gross deferred tax assets

 

 

49,131

 

 

 

65,495

 

Valuation allowance

 

 

(36,009

)

 

 

(51,794

)

Total deferred tax assets

 

$

13,122

 

 

$

13,701

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Property, plant, equipment and intangibles

 

$

(2,169

)

 

$

(1,651

)

Operating lease ROU assets

 

 

(5,979

)

 

 

(6,862

)

Foreign taxes

 

 

(1,639

)

 

 

(2,186

)

Total deferred tax liabilities

 

 

(9,787

)

 

 

(10,699

)

Total net deferred tax assets

 

$

3,335

 

 

$

3,002

 

 

Summary of Valuation Allowance

Under the incremental cash tax savings approach, the deferred tax asset valuation allowance activity was as follows (in thousands):  

 

 

 

Years Ended

 

 

 

2022

 

 

2021

 

 

2020

 

Balance at beginning of period

 

$

(51,794

)

 

$

(42,502

)

 

$

(37,007

)

Release (recapture) due to incremental cash tax savings

 

 

829

 

 

 

(845

)

 

 

495

 

Current year change due to deferred tax asset realization

 

 

14,956

 

 

 

(8,447

)

 

 

(5,990

)

Balance at end of period

 

$

(36,009

)

 

$

(51,794

)

 

$

(42,502

)

Schedule of Net Operating Loss Carryforwards

As of December 30, 2022, the Company had U.S. net operating loss (“NOL”) carryforwards consisting of the following (in thousands):

 

 

 

2022

 

 

Expiration Date

Pre-2018 federal NOL carryforwards

 

$

77,085

 

 

will begin to expire in 2023

Post-2018 federal NOL carryforwards

 

 

64,456

 

 

indefinite

State NOL carryforwards

 

 

56,314

 

 

will begin to expire in 2023

Schedule of Tax Credit Carryforwards

As of December 30, 2022, the Company had U.S. tax credit carryforwards consisting of the following (in thousands):

 

 

 

2022

 

 

Expiration Date

Federal research tax credit carryforwards

 

$

380

 

 

will begin to expire in 2030

State research tax credit carryforwards

 

 

785

 

 

indefinite

Federal foreign tax credit carryforwards

 

 

2,013

 

 

will begin to expire in 2028

 

Summary of Income Tax Examinations

The Company files income tax returns in the U.S. various states and foreign jurisdictions.  In the normal course of business, the Company is subject to examination by taxing authorities throughout the world.  The following tax years remain subject to examination:

 

Significant jurisdictions

 

Open Years

U.S. Federal

 

2019 – 2021

U.S. States

 

2018 – 2021

Foreign

 

2018 – 2021

Summary of Impact of Tax Holidays

The Company operates under a tax holiday in Switzerland, which is effective through 2024, and it may be extended through 2029 if certain additional requirements are satisfied. The tax holiday is conditional upon our meeting certain employment and investment thresholds. The impact of these tax holidays is as follows (in thousands, except per share amounts):

 

 

 

Years Ended

 

 

 

2022

 

 

2021

 

 

2020

 

Tax impact related to tax holidays

 

$

7,394

 

 

$

4,887

 

 

$

2,637

 

Impact of tax holidays on diluted earnings per share

 

$

0.14

 

 

$

0.10

 

 

$

0.05